X-twitter Linkedin Facebook-f Vimeo

SN

SN

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named...
SN

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...
SN

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...
SN

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...
SN

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by..
SN

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%...
SN

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...
SN

Smith & Nephew to host Capital Markets Days in London and New York

Smith & Nephew will hold Capital Markets Days on 8 December in London and 11 December in New York to outline its new strategy, mid-term priorities, and portfolio growth plans...
SN

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company..
SN

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership...
SN

Smith & Nephew Plc 12-Point Plan increasingly delivering better financial performance

Smith & Nephew reports strong financial results for 2024 with significant revenue and profit growth, driven by innovation and strategic restructuring...
SN

Smith & Nephew Plc delivers Q3 revenue of $1,412 million, 4% growth

Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled...
SN

Smith & Nephew Plc transforming into a higher growth and more profitable business

Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth...
Smith & Nephew

Smith & Nephew Q1 trading update shows revenue growth and confident outlook

Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook...
SN

Smith & Nephew reports Q4 revenue of $1,458 million, up 6.4%

Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024...
Smith & Nephew

Smith+Nephew to attend AAOS 2024, showcasing leading Orthopaedic solutions

Smith+Nephew plc (LON:SN, NYSE:SNN) will be attending AAOS 2024 Annual Meeting to showcase its innovative medical technology solutions in San Francisco. Learn about their latest products and updates in the..
Smith+Nephew

Smith+Nephew completes acquisition of Agili-C developer, CartiHeal

Smith+Nephew plc (LON:SN, NYSE:SNN), the global medical technology company, announces that it has completed the acquisition of CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in..

SN

Smith+Nephew Appoint Jez Maiden as Chair of the Audit Committee

Smith+Nephew Plc (LON:SN, NYSE: SNN), the global medical technology business, has announced that Rick Medlock has notified the Board of his decision not to submit himself for re-election as a..

SN

Smith & Nephew holding ‘Meet the Management’ event today

Smith+Nephew plc (LON:SN, NYSE:SNN), the global medical technology company, will today hold a Meet the Management event for institutional investors and analysts from 12:30pm GMT (7:30am EST), as previously announced...

Smith+Nephew

Smith+Nephew to acquire CartiHeal, developer of Agili-C

Smith+Nephew plc (LON:SN, NYSE:SNN), the global medical technology company, has announced that it has entered into a definitive agreement to acquire CartiHeal, developer of Agili-C, a novel sports medicine technology..

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

SN

SN

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named...
SN

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...
SN

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...
SN

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...
SN

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership...
SN

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%...
SN

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...
SN

Smith & Nephew to host Capital Markets Days in London and New York

Smith & Nephew will hold Capital Markets Days on 8 December in London and 11 December in New York to outline its new strategy, mid-term priorities, and portfolio growth plans...
SN

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...
SN

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership...
SN

Smith & Nephew Plc 12-Point Plan increasingly delivering better financial performance

Smith & Nephew reports strong financial results for 2024 with significant revenue and profit growth, driven by innovation and strategic restructuring...
SN

Smith & Nephew Plc delivers Q3 revenue of $1,412 million, 4% growth

Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled...
SN

Smith & Nephew Plc transforming into a higher growth and more profitable business

Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth...
Smith & Nephew

Smith & Nephew Q1 trading update shows revenue growth and confident outlook

Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook...
SN

Smith & Nephew reports Q4 revenue of $1,458 million, up 6.4%

Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024...
Smith & Nephew

Smith+Nephew to attend AAOS 2024, showcasing leading Orthopaedic solutions

Smith+Nephew plc (LON:SN, NYSE:SNN) will be attending AAOS 2024 Annual Meeting to showcase its innovative medical technology solutions in San Francisco. Learn about their latest products and updates in the orthopaedic field...
Smith+Nephew

Smith+Nephew completes acquisition of Agili-C developer, CartiHeal

SN

Smith+Nephew Appoint Jez Maiden as Chair of the Audit Committee

SN

Smith & Nephew holding ‘Meet the Management’ event today

Smith+Nephew

Smith+Nephew to acquire CartiHeal, developer of Agili-C

Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

SN

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple